![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Strauch Ulrike Schölmerich Jürgen
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 309-322
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs to treat alcoholism
By Soyka Michael Rösner Susanne
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs to treat juvenile idiopathic arthritis
By Ruperto Nicolino Martini Alberto
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab was used successfully to treat pulmonary manifestations of Crohn's disease
Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for gastroesophageal reflux disease
Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. :